1. Home
  2. Live Updates
  3. மருந்து தொடர்புடையது பக்க விளைவுகள்

மருந்து தொடர்புடையது பக்க விளைவுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்து தொடர்புடையது பக்க விளைவுகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்து தொடர்புடையது பக்க விளைவுகள் Today - Breaking & Trending Today

Toxys Strengthens Executive Team with Appointment of a CSO


Toxys Strengthens Executive Team with Appointment of a CSO
Search jobs
Toxys Strengthens Executive Team with Appointment of a CSO
LEIDEN, The Netherlands, February 24, 2021 / B3C newswire / Today, Toxys announces the appointment of Torben Østerlund as Chief Scientific Officer (CSO). Toxys BV is a biotech company based in Leiden, The Netherlands, that provides innovative
in vitro toxicity screening solutions to identify hazardous properties of compounds for the pharmaceutical, chemical, cosmetics and food industries. Toxys developed the ToxTracker, ReproTracker and ToxProfiler assays that provide unique and highly valuable insight into the mode-of-action of toxic substances. With this strengthened leadership, Toxys will further accelerate business growth to become an industry-leader in animal-free chemical safety testing. ....

Giel Hendriks , Paula Van Rossum , Zealand Pharma , Lund University , Leiden University Medical Center , Odense University , Chief Scientific Officer , Molecular Biology , Leiden Bio Science , Chemical Safety , Food Industry , Drug Related Side Effects , Adverse Reactions , Toxicity Tests , Mutagenicity Tests , Cell Tracking , Consumer Product Safety , Animal Testing Alternatives , ஜீலாந்து பார்மா , லண்ட் பல்கலைக்கழகம் , தலைமை அறிவியல் அதிகாரி , மூலக்கூறு உயிரியல் , இரசாயன பாதுகாப்பு , உணவு தொழில் , மருந்து தொடர்புடையது பக்க விளைவுகள் , செல் கண்காணிப்பு ,

Toxys, Leiden University and Leiden University Medical Center Announce Licensing of ToxProfiler Technology for Animal-Free Chemical Safety Testing


 
Toxys will immediately commercialize and develop further the in vitro reporter technology for mechanistic toxicity testing to improve the human safety assessment of novel medicines, chemicals and cosmetic ingredients.
LEIDEN, The Netherlands, January 28, 2021 / B3C newswire / Toxys, Leiden University and Leiden University Medical Center have agreed immediately to commercialize and also develop further the ToxProfiler technology invented at the two institutions. ToxProfiler allows for rapid toxicity hazard identification of novel and existing drugs, chemicals, and other substances. Furthermore, ToxProfiler has the unique ability to provide detailed and quantitative information about the mode-of-action of such toxic substances. This new technology thereby enormously enlarges the portfolio of toxicity testing that Toxys can make available to the world, complementing the existing genotoxicity and repro-toxicity testing platforms of Toxys. ....

Giel Hendriks , Paula Van Rossum , Leiden University Medical Centre , Leiden Academic Centre Of Drug Research , Leiden University Medical Center , Professor Of Drug Safety Sciences , Leiden Academic Centre For Drug Research , Leiden University , Dutch Federation Of University Medical Centres , Leiden Academic Centre , Drug Research , New Approach Method , Scientific Director , Drug Safety Sciences , Leiden Bio Science , Leiden Bio Science Park , Dutch Federation , University Medical Centres , Chemical Safety , Food Industry , Toxicity Tests , Drug Related Side Effects , Adverse Reactions , Mutagenicity Tests , Cell Tracking , Consumer Product Safety ,